LOGIN  |  REGISTER
Chimerix
Cue Biopharma

Charles River Laboratories Launches Real-Time Research Model Ordering, Introducing an Important Digital Innovation to Research Models & Services Business

October 19, 2023 | Last Trade: US$178.58 2.81 -1.55

WILMINGTON, Mass. / Oct 19, 2023 / Business Wire / Charles River Laboratories International, Inc. (NYSE: CRL) today announced a new e-commerce ordering experience, offering clients real-time access into research model availability and pricing, as well as immediate order confirmation. The introduction of real-time ordering for Charles River’s Research Models & Services business digitizes a robust, industry-leading inventory, and provides a seamless online ordering experience.

“Traditionally, clients looking to purchase research models would review a static digital catalog, and follow-up with a phone call or email to our ordering team,” said Colin Dunn, Ph.D., Corporate Senior Vice President, Global Research Models & Services, Charles River. “Our real-time digital experience reimagines this dynamic and enables clients direct access to availability, pricing, and immediate order confirmations–empowering them to make more efficient decisions.”

By reimagining an interactive digital catalog and connecting it to dynamic inventory and pricing systems, clients are now provided with real-time purchasing information based on their delivery schedule. The intuitive digital experience enables collaboration between researchers and procurement teams to search inventory by name, species, strain code or therapeutic area, and configure their request based on research model specifications matching their study requirements and schedule.

“Implementing this real-time experience in our Research Models & Services business is the latest in a series of innovations that are fundamental to our digital journey,” said Mark Mintz, Corporate Senior Vice President, Chief Information Officer at Charles River. “We built this platform with client needs in mind, using design-led thinking to create value in their research process, ultimately working to increase efficiency in the development of new therapeutics.”

As part of Charles River’s commitment to the humane care and well-being of research animal models, trained staff qualify all requests for account access, ensuring that only authorized individuals have the ability to place orders for research models. Researchers have full access to Charles River’s research model portfolio, including account-specific pricing for effortless sharing with their procurement team to streamline purchases. As more users are onboarded onto the innovative platform, the online ordering system ensures seamless collaboration for researchers, regardless of procurement platform. The real-time ordering experience is live and currently available in North America. Charles River is continuously expanding the scope and taking into account the voice of the customer, and anticipates new features being regularly introduced.

“[It is] more convenient and easier to find the research models requested from my researchers,” said Michelle, a purchasing administrator at Case Western Reserve University. “I really like the fact that all my account and shipping information is already in the system for me to choose from. I like that I can see the price of the research models we are requesting when placing an order. We also get the confirmations back very quickly.”

Charles River is showcasing the real-time research model ordering experience at the AALAS 2023 National Meeting in Salt Lake City, UT, from October 22-26. Visit Booth #1908 for a demonstration from subject matter experts, and to see the latest innovations from Charles River.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

Viking Therapeutics

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB